Edgewise Therapeutics (EWTX) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.47
-0.42
-0.38
-0.33

Details

Expected EPS
-0.3913
Actual EPS
-0.33
Surprise EPS
0.06
Surprise Percent
+15.67%

Description

Edgewise Therapeutics (EWTX) has reported earnings of -0.33 per share for Q2 2024.

0 Comments

Share your thoughts